Chartwell is pleased to announce that Chemonics International, Inc. (“Chemonics” or the “Company”) has successfully completed a refinancing of its existing senior debt credit facility. The new facility provides the Company with significant financial flexibility and capacity to support its new business initiatives and long-term strategic plans. Chartwell acted as the exclusive financial advisor to Chemonics, providing counsel to the senior management team on all facets of the transaction.
In the refinancing, Truist and Citibank are the senior lenders to Chemonics and provide the capital to support the Company’s growth initiatives through a cash-flow based revolving credit facility that maximizes operating flexibility. Additionally, Chemonics has access to incremental capital through an accordion feature that allows the Company to upsize the revolving credit facility to further finance organic and inorganic opportunities in support of its strategic objectives.
Chemonics is a leading international development consulting firm applying a suite of consulting services to foreign aid operations in over 80 countries across the globe. The Company provides an extensive array of services in areas such as health, government, agriculture, education, supply chain administration, aid distribution, humanitarian assistance, and more. With a long-term track record of successful project implementation, Chemonics has earned a reputation as the go-to executor of development assistance goals for a host of governments, NGOs, and charities worldwide. Chemonics is a 100% ESOP-owned business and prides itself on generating value for its employee ownership base.
For additional information on this transaction, please contact Ryan Rassin.
To learn more about Chartwell’s corporate finance capabilities, please contact Greg Fresh.